Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Safer sedation for seniors: study pinpoints dose for frail elderly

NCT ID NCT07467603

Knowledge-focused Sponsor: The First Hospital of Hebei Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 58 frail elderly patients (65+) to find the best dose of remimazolam, a sedative used for anesthesia. Researchers used a special monitor to track breathing and adjusted doses carefully. The goal is to help doctors give just enough medicine to put patients to sleep without causing breathing problems.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Remimazolam (a short-acting sedative)
What this could lead to
If successful, this could help doctors give safer anesthesia doses to frail older adults, reducing breathing problems.
What could go wrong
This is a small, early-stage study with only 58 people. Results may not apply to all frail elderly patients or those with other health issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Feb 2025

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged ≥65 years; * Scheduled for elective surgery under general anesthesia with endotracheal intubation; * American Society of Anesthesiologists (ASA) physical status II or III; * Body Mass Index (BMI) between 18 and 30 kg/m². Exclusion Criteria: * Known allergy to benzodiazepines; * History of severe respiratory or cardiovascular disease (e.g., acute heart failure, severe COPD); * Long-term use of sedatives, analgesics, or alcohol abuse; * Known neuromuscular disorders (e.g., myasthenia gravis); * Inability to communicate for sedation assessment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anesthesia induction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Frailty

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anesthesia induction Frailty

Contacts and locations

Locations

  • Second Hospital of Hebei Medical University

    Shijiazhuang, Hebei, 050000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.